Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Baylin

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Cancer Research|June 17, 2006
Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasmsSteven D Gore, Stephen Baylin, Elizabeth Sugar, et al.
Oncotarget|February 11, 2017
Combination epigenetic therapy in metastatic colorectal cancer (mCRC) with subcutaneous 5-azacitidine and entinostat: a phase 2 consortium/stand up 2 cancer studyNilofer S Azad, Anthony El-Khoueiry, Jun Yin, et al.
Cell Reports|August 25, 2021
Evaluating the impact of age on immune checkpoint therapy biomarkersRossin Erbe, Zheyu Wang, Sharon Wu, et al.
Science (New York, N.Y.)|October 10, 2024
Epigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapyTae Gun Kang, Xin Lan, Tian Mi, et al.
Cell Reports. Medicine|September 4, 2025
Epigenetic modulation of BARD1 to enhance anti-VEGF therapyEmine Bayraktar, Cristian Rodriguez-Aguayo, Elaine Stur, et al.
Nature Communications|June 11, 2024
Space radiation damage rescued by inhibition of key spaceflight associated miRNAsJ Tyson McDonald, JangKeun Kim, Lily Farmerie, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Cancer Research|June 17, 2006
Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasmsSteven D Gore, Stephen Baylin, Elizabeth Sugar, et al.
Oncotarget|February 11, 2017
Combination epigenetic therapy in metastatic colorectal cancer (mCRC) with subcutaneous 5-azacitidine and entinostat: a phase 2 consortium/stand up 2 cancer studyNilofer S Azad, Anthony El-Khoueiry, Jun Yin, et al.
Cell Reports|August 25, 2021
Evaluating the impact of age on immune checkpoint therapy biomarkersRossin Erbe, Zheyu Wang, Sharon Wu, et al.
Science (New York, N.Y.)|October 10, 2024
Epigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapyTae Gun Kang, Xin Lan, Tian Mi, et al.
Cell Reports. Medicine|September 4, 2025
Epigenetic modulation of BARD1 to enhance anti-VEGF therapyEmine Bayraktar, Cristian Rodriguez-Aguayo, Elaine Stur, et al.
Nature Communications|June 11, 2024
Space radiation damage rescued by inhibition of key spaceflight associated miRNAsJ Tyson McDonald, JangKeun Kim, Lily Farmerie, et al.
Pageof 2